EP3595613A1 - Système d'alimentation entérale fermé pour le drainage de liquide gastrique - Google Patents

Système d'alimentation entérale fermé pour le drainage de liquide gastrique

Info

Publication number
EP3595613A1
EP3595613A1 EP18711074.7A EP18711074A EP3595613A1 EP 3595613 A1 EP3595613 A1 EP 3595613A1 EP 18711074 A EP18711074 A EP 18711074A EP 3595613 A1 EP3595613 A1 EP 3595613A1
Authority
EP
European Patent Office
Prior art keywords
tube
container
valve
orientation
flow path
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18711074.7A
Other languages
German (de)
English (en)
Inventor
Nicole Nadja HOLENWEG
SCARTAZZINI Felix ZÜRCHER
Ottilia Magdalena ROHRER
Nicolas ANDREY
Michael Reuben JEDWAB
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Bern
Axium Mtech SA
Original Assignee
Universitaet Bern
Axium Mtech SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Bern, Axium Mtech SA filed Critical Universitaet Bern
Publication of EP3595613A1 publication Critical patent/EP3595613A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/0096—Provisions for venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00—Feeding-tubes for therapeutic purposes
    • A61J15/0026—Parts, details or accessories for feeding-tubes
    • A61J15/0092—Valves on feeding tubes

Definitions

  • the present disclosure generally relates to a closed enteral feeding system. More specifically, the present disclosure is directed to a system comprising a tube through which enteral feeding, medication, and active aspiration (e.g., gastric fluid drainage) can be provided.
  • enteral feeding, medication, and active aspiration e.g., gastric fluid drainage
  • the human body derives its resources mainly from ingested food.
  • patients may not be able to ingest sufficient amounts of food without help, for example hospitalized patients after surgery and/or in critical care conditions.
  • Such patients may be unable or unwilling to accept oral feedings in sufficient amounts.
  • enteral tube feedings are a valuable option to ensure proper nutrition that allows a quick recovery.
  • indications for enteral nutrition include anorexia, protein undernutrition, liver failure, bowel preparation for surgery, closure of enterocutaneous fistulas, small-bowel adaptation after massive intestinal resection or in disorders that may cause malabsorption, inability to take oral feedings, trauma, and/or critical illness causing metabolic stress.
  • Enteral tube feedings can provide the required nourishment and/or medication in a medical flowable material, such as a fluid, through a patient feeding line of an enteral administration system that is connected to a container containing the medical flowable material.
  • the system can use a feeding tube, such as a nasogastric or nasojejunal tube, to deposit the medical flowable material directly into the gastrointestinal tract at a point beyond the mouth, for example directly into the stomach, duodenum or jejunum.
  • the present disclosure is generally directed to administering a composition containing at least one of a nutrient or a medication to a patient through an enteral feeding tube, and the same enteral feeding tube can be used for active aspiration such as gastric fluid drainage.
  • the gastric fluid can be aspirated with syringe, then a valve can be switched to empty the syringe into a container attached to a port of the syringe, the volume of the gastric fluid can be measured, and after aspiration and collection of the gastric fluid are completed, the container can be discharged (e.g., thrown away) and/or the gastric fluid can be reinfused into the stomach.
  • a closed system can facilitate the enteral feeding and the active aspiration.
  • the system can have at least three configurations that can be achieved without the need to add or remove components, namely a feeding configuration, an aspiration (e.g., gastric emptying) configuration, and a reinfusion configuration.
  • One or more devices in the system can each be selectively moved between at least two orientations, and the selected orientation(s) of the one or more devices in the system can establish the desired configuration of the system.
  • the present disclosure provides a method comprising supplying a composition to a patient from a system comprising a first container.
  • the system further comprises a first tube comprising a first end fiuidly connected to the first container, and the first tube comprises a second end fiuidly connected to a first three-way junction to which a first end of a second tube and a vessel are fiuidly connected.
  • the second tube comprises a second end fiuidly connected to a second three-way junction to which a first end of a third tube and a second container are fiuidly connected.
  • the third tube comprises a second end leading toward the patient.
  • the supplying of the composition comprises directing the composition from the first container in a first flow path comprising the first tube, the second tube and the third tube and leading into the gastrointestinal tract of the patient while blocking the composition from the vessel and the second container using one or more devices, for example one or more valves that can be positioned at a location selected from (i) the first three-way junction, (ii) the second three-way junction, and (iii) both the first and second three-way junctions.
  • the preferred embodiment of the method comprises withdrawing gastric fluid from the gastrointestinal tract of the patient into the vessel while the one or more devices block the composition from the second container and the vessel and block the gastric fluid from the first tube and the second container (e.g., by blocking the second container and the second end of the first tube).
  • the withdrawing of the gastric fluid comprises using at least one of the one or more devices to establish a second flow path comprising the second tube and the third tube and leading into the vessel.
  • the preferred embodiment of the method comprises directing the gastric fluid in a third flow path from the vessel into the second container while the one or more devices block the gastric fluid from the first and third tubes and block the composition from the vessel and the second tube (e.g., by blocking the second end of the first tube and the first end of the third tube).
  • the third flow path can comprise the second tube.
  • the method can further comprise reinfusion of the gastric fluid from the second container to the gastrointestinal tract of the patient, for example by directing the gastric fluid from the second container to the gastrointestinal tract or by directing the gastric fluid from the second container to the vessel and then to the gastrointestinal tract of the patient.
  • the present disclosure provides a method of selectively providing a composition to a patient and active gastric aspiration for the patient.
  • An advantage of one or more embodiments provided by the present disclosure is a closed enteral feeding system. This system can minimize or eliminate the odor, mess, and risk of contamination associated with a process of gastric emptying, measuring the withdrawn volume, and reinfusing the gastric fluid.
  • Another advantage of one or more embodiments provided by the present disclosure is to selectively switch between enteral feeding and gastric emptying without the need to remove the feeding bag.
  • Still another advantage of one or more embodiments provided by the present disclosure is a closed enteral feeding system that hygienically supplies medication and/or other interventions to the patient.
  • Yet another advantage of one or more embodiments provided by the present disclosure is a system of enteral feeding and gastric emptying that is easy to use.
  • a further advantage of one or more embodiments provided by the present disclosure is an enteral feeding system with improved patient comfort.
  • Another advantage of one or more embodiments provided by the present disclosure is to allow measurement of gastric fluid using a syringe and/or graduated bag.
  • a further advantage of one or more embodiments provided by the present disclosure is an enteral feeding system that allows reinfusion of gastric fluids into the stomach, for example at different amounts according to patient clinical practice.
  • FIG. 1 depicts a preferred embodiment of a system according to the present disclosure in a feeding configuration.
  • FIG. 2 depicts the preferred embodiment of the system in a gastric fluid withdrawal configuration.
  • FIG. 3 depicts the preferred embodiment of the system in a drainage container filling configuration.
  • FIG. 4 depicts the preferred embodiment of the system in a first reinfusion configuration.
  • FIG. 5 depicts the preferred embodiment of the system in a first stage of a second reinfusion configuration.
  • FIG. 6 depicts the preferred embodiment of the system in a second stage of a second reinfusion configuration.
  • FIG. 7 depicts a second embodiment of a system according to the present disclosure in a feeding configuration.
  • FIG. 8 depicts the second embodiment of the system in a gastric fluid withdrawal configuration.
  • FIG. 9 depicts the second embodiment of the system in a drainage container filling configuration.
  • FIG. 10 depicts the second embodiment of the system in a first reinfusion configuration.
  • FIG. 11 depicts the second embodiment of the system in a first stage of a second reinfusion configuration.
  • FIG. 12 depicts the second embodiment of the system in a second stage of a second reinfusion configuration.
  • FIG. 13 depicts a third embodiment of a system according to the present disclosure in a feeding configuration.
  • FIG. 14 depicts the third embodiment of the system in a gastric fluid withdrawal configuration.
  • FIG. 15 depicts the third embodiment of the system in a drainage container filling configuration.
  • FIG. 16 depicts the third embodiment of the system in a first reinfusion configuration.
  • FIG. 17 depicts the third embodiment of the system in a first stage of a second reinfusion configuration.
  • FIG. 18 depicts the third embodiment of the system in a second stage of a second reinfusion configuration.
  • FIG. 19 depicts a fourth embodiment of a system according to the present disclosure in a feeding configuration.
  • FIG. 20 depicts the fourth embodiment of the system in a gastric fluid withdrawal configuration.
  • FIG. 21 depicts the fourth embodiment of the system in a drainage container filling configuration.
  • FIG. 22A is a schematic diagram of a configuration in which the system is connected to an upstream administration set.
  • FIG. 22B is a schematic diagram of a configuration in which the system is connected to a downstream administration set.
  • the devices and apparatuses disclosed herein may lack any element that is not specifically disclosed.
  • a disclosure of an embodiment using the term “comprising” includes a disclosure of embodiments “consisting essentially of and “consisting of the components identified.
  • the methods disclosed herein may lack any step that is not specifically disclosed herein.
  • a disclosure of an embodiment using the term “comprising” includes a disclosure of embodiments “consisting essentially of and “consisting of the steps identified.
  • connection and attachment do not require direct connection or attachment and encompass connections and attachments that include one or more intermediate pieces that connect or attach the referenced components.
  • Fluidly connected means that the referenced components can convey fluids (i.e., gases and liquids) between each other directly or by one or more intermediate pieces. This term does not mean that the fluidly connected components must convey fluids between each other in every mode of the system, but rather that the system can be selectively arranged in at least one mode in which the fluidly connected components convey fluids between each other. There may be other modes in which the fluidly connected components convey fluids between each other, for example if a particular valve orientation is employed.
  • reversibly movable means that the referenced component can be moved relative to another component without damaging any of these components and without damaging a connector, if any, and preferably without requiring any tools.
  • reversibly removable means that the referenced component can be disconnected from another component and then reconnected to the other component without damaging any of these components and without damaging a connector, if any, and preferably without requiring any tools.
  • a "closed" enteral system is a system for which the entirety of the interior of the system is completely closed to the environment in which it is situated when all of the components are connected.
  • any openings in the system are preferably covered by a component of the system, and any removable components of the system are preferably reconnectable.
  • the terms “block,” “block,” “close” and “closing” mean that the fluid cannot flow through the referenced component.
  • “blocking" a container means that fluid cannot enter the container, i.e., no opening is available in the system to provide fluid entry to the container.
  • blocking" an end of a tube means that fluid cannot exit the end of the tube into the immediately adjacent component.
  • “blocking" a tube means that fluid cannot travel from one end of the tube to the other end of the tube.
  • configuration refers to an arrangement of the closed enteral system.
  • the closed enteral system is capable of selectively establishing one of a plurality of fluid flow paths through the system, and each of the configurations of the system can establish one or more specific fluid flow paths.
  • the system can switch between configurations without the need to add or remove any components.
  • the system switches between configurations by a user selectively changing the orientation of one or more devices in the system.
  • An "orientation" of a device refers to the alignment of the device relative to its adjacent components, e.g., pointing upward, pointing downward, pointing downstream, or pointing upstream. Changing the "orientation" of the device does not change its location within the system; i.e., the identity of the immediately upstream component and the identity of the immediately downstream component remains the same when the orientation of the device is changed.
  • Numerical adjectives such as “first” and “second,” are merely used to distinguish components. These numerical adjectives do not imply the presence of other components, a relative positioning, or any chronological implementation. In this regard, the presence of a “second tube” does not imply that a “first tube” is necessarily present. Further in this regard, a “second tube” can be used before, after, or simultaneously with any “first tube.”
  • FIGS. 1-6 show a first and particularly preferred embodiment of a closed enteral feeding system 10 (hereafter "the system 10") that can be used to supply a composition 21 from a first container 20 to a patient.
  • the composition 21 can be an enteral formula comprising at least one of a nutrient or a medication. Nevertheless, the composition 21 can be any liquid formula that can be delivered into a patient's digestive system from the system 10, for example in a clinical or intensive care unit (ICU) setting and/or a home.
  • the first container 20 can be any container suitable for holding and dispensing the composition, such as an enteral feeding bag, and the present disclosure is not limited to a specific embodiment of the first container 20.
  • the system 10 can comprise a first tube 30, a second tube 40, and a third tube 50 that form a first flow path leading from the first container 20 to the patient.
  • the system 10 can be distal or proximal to an administration set.
  • the first container 20 can be connected to the first tube 30 by an administration set.
  • the third tube 50 can be connected to the patient by an administration set.
  • the first tube 30 can be fluidly connected to the second tube 40, preferably at a first three-way junction.
  • the first three-way junction has at least three openings and is not limited to only three openings, although a preferred embodiment of the first three-way junction does indeed have only three openings.
  • the first tube 30 can comprise a first end 31 attached to and/or fluidly connected to the first container 20 and can comprise a second end 32 attached to and/or fluidly connected to a first end 41 of the second tube 40, for example at the first three-way junction.
  • the first tube 30 can convey the composition 21 from the first container 20 to the second tube 40.
  • the first end 31 of the first tube 30 can be directly attached to the first container 20 or can be attached to the first container 20 by a first intermediate connector 25.
  • the first end 41 of the second tube 40 and/or the second end 32 of the first tube 30 can be removably attached to or integral with the first three-way junction.
  • the second end 32 of the first tube 30 can be fluidly connected to the first end 41 of the second tube 40 by a first valve 60, for example at the first three-way junction.
  • the first valve 60 is a single valve that selectively moves between at least two orientations, each of the orientations forming a different flow path than the other orientation(s).
  • the first valve 60 can be an L-port valve that selectively closes one of three openings of the first valve 60 and fluidly connects the other two openings of the first valve 60.
  • the first valve 60 is preferably a three-way valve, but instead can be a two-way valve if the system 10 also uses one or more clips, for example one clip or three clips.
  • a vessel 71 e.g., a hollow cylinder, preferably provided by a syringe 70 and discussed in more detail hereafter
  • a vessel 71 can be selectively fluidly connected to the second end 32 of the first tube 30 or the first end 41 of the second tube 40 by the first valve 60, e.g., at the first three-way junction.
  • the third tube 50 can comprise a first end 51 removably attached to or integral with a second three-way junction.
  • the second end 42 of the second tube 40 and/or the first end 51 of the third tube 50 can be removably attached to or integral with a second valve 65.
  • the second valve 65 is a single valve that selectively moves between at least two orientations, each of the orientations forming a different flow path than the other orientation(s).
  • the second valve 65 can be an L-port valve that selectively closes one of three openings of the second valve 65 and fluidly connects the other two openings of the second valve 65.
  • the second valve 65 is preferably a three-way valve, but instead can be a two- way valve if the system 10 also uses one or more clips, for example one clip or three clips.
  • the third tube 50 can comprise a second end 52 that can be attached to or integral with an enteral feeding tube, for example a nasogastric tube, a nasojejeunal tube, a naso- duodenal tube, an orogastric tube, or a percutaneous tube, and/or attached to an administration set.
  • an enteral feeding tube for example a nasogastric tube, a nasojejeunal tube, a naso- duodenal tube, an orogastric tube, or a percutaneous tube, and/or attached to an administration set.
  • the second end 52 of the third tube 50 can be directly attached to the enteral feeding tube or can be attached to the enteral feeding tube by a second intermediate connector 45.
  • the third tube 50 itself can function as the enteral feeding tube.
  • the second valve 65 can selectively direct gastric fluid from the patient into a second container 80 fluidly connected to the first end 51 of the third tube 50, for example at the second three-way junction.
  • the second container 80 can be any container suitable for receiving and holding the gastric fluid, such as a collection bag (e.g., a bag made of a disposable material), and the present disclosure is not limited to a specific embodiment of the second container 80.
  • the second container 80 can be directly attached to or integral with the second three-way junction, e.g., with the second valve 65.
  • the second container 80 can be fluidly connected to the second three-way junction by a fourth tube 57.
  • a third intermediate connector 81 removably connects the second container 80 to the second valve 65 and/or the fourth tube 57.
  • the second three-way junction has at least three openings and is not limited to only three openings, although a preferred embodiment of the second three-way junction does indeed have only three openings.
  • the syringe 70 can be upstream from the second container 80 (e.g., distal from the patient).
  • the syringe 70 can be removably attached to or integral with the first valve 60, e.g., a socket 61 of the first valve 60.
  • the syringe 70 can have a plunger 72 that fits tightly in the vessel 71 and can be pulled or pushed inside the vessel 71 to respectively pull in or expel a liquid or gas through an orifice at an open end of the vessel 71; the open end can be attached to the first valve 60.
  • the first valve 60 preferably moves between at least two orientations, for example a first orientation in which the socket 61 is closed and the second end 32 of the first tube 30 and the first end 41 of the second tube 40 are in fluid communication, and a second orientation in which the second end 32 of the first tube 30 is closed and the first end 41 of the second tube 40 and the syringe 70 and are in fluid communication.
  • the first valve 60 is moved between the first and second orientations by rotation of a stopcock provided by the first valve 60.
  • rotation of the stopcock in one direction can move the first valve 60 from the first orientation to the second orientation
  • rotation of the stopcock in the opposite direction e.g., about 90 degrees
  • the second valve 65 preferably moves between at least two orientations, for example a first orientation in which the second container 80 is closed and the second end 42 of the second tube 40 and the first end 51 of the third tube 50 are in fluid communication, and a second orientation in which the first end 51 of the third tube 50 is closed and the second end 42 of the second tube 50 and the second container 80 are in fluid communication.
  • the second valve 65 is moved between the first and second orientations by rotation of a stopcock provided by the second valve 65.
  • rotation of the stopcock in one direction can move the second valve 65 from the first orientation to the second orientation
  • rotation of the stopcock in the opposite direction e.g., about 90 degrees
  • the second valve 65 moves between at least three orientations, for example the first and second orientations noted above and additionally a third orientation in which the second end 42 of the second tube 40 is closed and the first end 51 of the third tube 50 and the second container 80 are in fluid communication.
  • the second valve 65 is moved between the first, second and third orientations by rotation of a stopcock provided by the second valve 65 (e.g., in about 90 degree increments).
  • the first embodiment of the system 10 can be in a feeding configuration.
  • the first valve 60 can be in the first orientation fiuidly connecting the second end 32 of the first tube 30 to the first end 41 of the second tube 40, preferably while closing the socket 61
  • the second valve 65 can be in the first orientation fiuidly connecting the second end 42 of the second tube 40 to the first end 51 of the third tube 50, preferably while closing the second container 80.
  • the composition 21 can flow from the first container 20 through the first tube 30, then through the first valve 60, then through the second tube 40, then through the second valve 65 and then through the third tube 50 to the patient, e.g., by gravity or a pump (first flow path, shown by the dashed arrow in this figure).
  • the first embodiment of the system 10 can move from the feeding configuration to a gastric fluid withdrawal configuration.
  • the first valve 60 can be moved into the second orientation fiuidly connecting the first end 41 of the second tube 40 to the syringe 70 and closing the second end 32 of the first tube 30.
  • the plunger 72 of the syringe 70 can be withdrawn from the vessel 71 to pull the gastric fluid through the third tube 50, then through the second valve 65, then through the second tube 40, and then through the first valve 60 into the vessel 71 of the syringe 70 (second flow path, shown by the dashed arrow in this figure).
  • only a portion of the gastric fluid in the patient is removed by one pull of the plunger 72 (i.e., typically one pull of the plunger 72 will not completely empty the gastric fluid from the patient).
  • the volume of the gastric fluid 85 withdrawn into the system 10 can be measured if desired, for example in the syringe 70 and/or the second container 80 using indicia 79 visible thereon.
  • the first embodiment of the system 10 can move from the gastric fluid withdrawal configuration to a drainage container filling configuration, e.g., after the gastric fluid withdrawal configuration is used to withdraw a desired amount of the gastric fluid into the syringe 70 and/or after the system 10 has been in the gastric fluid withdrawal configuration for a desired time period.
  • the second valve 65 can be moved into the second orientation closing the first end 51 of the third tube 50 and fluidly connecting the second end 42 of the second tube 40 and the second container 80.
  • the plunger 72 of the syringe 70 can be pushed into the vessel 71 to direct the gastric fluid 85 from the vessel 71 of the syringe 70, then through the first valve 60, then through the second tube 40, then through the second valve 65 and into the second container 80 (third flow path, shown by the dashed arrow in this figure).
  • the drainage container filling configuration shown in FIG. 3 can be used to block all flow through the system 10.
  • the third flow path depicted by the dashed arrow occurs when the plunger 72 of the syringe 70 is pushed into the vessel 71; if the system 10 is in the drainage container filling configuration and the plunger 72 is not pushed or pulled, then the system 10 can be static with flow therethrough blocked.
  • the first embodiment of the system 10 can be returned to the feeding configuration shown in FIG. 1.
  • moving the first valve 60 into the first orientation and moving the second valve 65 into the first orientation can arrange the first embodiment of the system 10 into the feeding configuration.
  • additional gastric fluid can be withdrawn by moving the first embodiment of the system 10 from the drainage container filling configuration shown in FIG. 3 back to the gastric fluid withdrawal configuration shown in FIG. 2.
  • moving the second valve 65 from the second orientation, which closes the first end 51 of the third tube 50, to the second orientation, which fluidly connects the third tube 50 to the syringe 70 via the second tube 40 and closes the second container 80 can arrange the system 10 into the gastric fluid withdrawal configuration.
  • the additional gastric fluid can be withdrawn through the third tube 50, the second valve 65, the second tube 40 and the first valve 60 into the vessel 71 of the syringe 70 (second flow path, shown by the dashed arrow in FIG. 2).
  • the additional gastric fluid can be directed into the second container 80 using the drainage container filling configuration shown in FIG. 3 (third flow path, shown by the dashed arrow in this figure).
  • the system 10 can move back and forth between the gastric fluid withdrawal configuration and the drainage container filling configuration as many times as desired by the user, until a capacity of the second container 80 is reached, or preferably until the stomach of the patient has been emptied of gastric fluid.
  • the volume of the withdrawn gastric fluid can be measured at any time in this process, for example at least at the end (e.g., the stomach of the patient has been emptied of gastric fluid), for example using the indicia 79 visible on the syringe 70 and/or the second container 80.
  • the second container 80 can be removed from the second valve 65, for example when the system 10 is positioned in one of the feeding configuration and the gastric fluid withdrawal configuration.
  • the second container 80 can be reversibly removed from the second valve 65 by removing the second container 80 from the third intermediate connector 81 and/or by removing the third intermediate connector 81 from the second valve 65.
  • a subsequent action can be selected from the group consisting of (i) discarding the second container 80 and attaching a new second container 80 to the second valve 65, (ii) dispensing at least a portion of the gastric fluid from the second container 80 and then reconnecting the second container 80 to the second valve 65, and (iii) completely removing the second container 80.
  • the second container 80 can be reconnected to the second valve 65 by reconnecting the second container 80 to the third intermediate connector 81 and/or by reconnecting the third intermediate connector 81 to the second valve 65, for example when the system 10 is positioned in one of the feeding configuration or the gastric fluid withdrawal configuration.
  • the syringe 70 can be removed from the first valve 60.
  • the syringe 70 can be reversibly removed from the first valve 60 by removing the syringe 70 from the socket 61.
  • a subsequent action can be selected from the group consisting of (i) discarding the syringe 70 and attaching a new syringe 70 to the first valve 60, (ii) dispensing at least a portion of the gastric fluid from the syringe 70 and then reconnecting the syringe 70 to the first valve 60, and (iii) completely removing the syringe 70.
  • the syringe 70 can be reconnected to the first valve 60 by reconnecting the syringe 70 to the socket 61.
  • the first embodiment of the system 10 can move from one of the feeding configuration, the gastric fluid withdrawal configuration, and the drainage container filling configuration to a first reinfusion configuration, e.g., after the drainage container filling configuration is used to direct a desired amount of the gastric fluid into the second container 80 and/or after the system 10 has been in the drainage container filling configuration for a desired time period.
  • the second valve 65 can be moved into the third orientation closing the second end 42 of the second tube 40 and fluidly connecting the first end 51 of the third tube 50 and the second container 80.
  • the gastric fluid 85 can be directed from the second container 80 through the second valve 65 and then through the third tube 50 into the gastrointestinal tract of the patient (fourth flow path, shown by the dashed arrow in this figure).
  • an embodiment of the second container 80 is at least partially flexible so that compression of the second container 80 can force the gastric fluid 85 from the second container 80 through the third tube 50 into the gastrointestinal tract of the patient.
  • the first valve 60 can be in any orientation for the first reinfusion configuration, and the first reinfusion configuration does not require a specific orientation of the first valve 60.
  • FIGS. 5 and 6 A second reinfusion configuration of the first embodiment of the system 10 is shown in FIGS. 5 and 6. This reinfusion configuration is particularly advantageous if the second container 80 is rigid, although this reinfusion configuration can be employed even if the second container 80 is partially flexible.
  • FIG. 5 a first stage of the second reinfusion configuration of the first embodiment of the system 10 is shown.
  • the second valve 65 can be in the second orientation in which the first end 51 of the third tube 50 is blocked and the second container 80 is fluidly connected to the second end 42 of the second tube 40
  • the first valve 60 can be in the second orientation in which the second end 31 of the first tube 30 is blocked and the vessel 71 is fluidly connected to the first end 41 of the second tube 40.
  • the second tube 40 can fluidly connect the second container 80 and the vessel 71.
  • FIG. 6 a second stage of the second reinfusion configuration of the first embodiment of the system 10 is shown.
  • the system 10 can be moved from the first stage to the second stage of the second reinfusion configuration by moving the second valve 65 from the second orientation to the first orientation in which the second container 80 is blocked and the second end 42 of the second tube 40 is fiuidly connected to the first end 51 of the third tube 50.
  • the second tube 40 can fiuidly connect the third tube 50 and the vessel 71. Then the plunger 72 of the syringe 70 can be pushed into the vessel 71 to direct the gastric fluid from the vessel 71 through the first valve 60, then through the second tube 40, then through the second valve 65, then through the third tube 50 and then into the gastrointestinal tract of the patient (sixth flow path, shown by the dashed arrow in this figure).
  • the user may perform reinfusion by alternating the first and second stages of the second reinfusion configuration as many times as needed or desired.
  • the first container 20 remains attached to the first tube 30 and/or the first intermediate connector 25 (i.e., the first container 20 is not removed therefrom) throughout movement of the system 10 from the feeding configuration to the gastric fluid withdrawal configuration to the drainage container filling configuration to the reinfusion configuration and back to the feeding configuration.
  • the positions of the first container 20 and the second container 80 can be switched. Specifically, the first container 20 can be positioned where the second container 80 is shown in FIGS. 1-6 while the second container 80 can be positioned where the first container 20 is shown in FIGS. 1-6. Accordingly, the first container 20 and the second container 80 can switch positions without affecting the functionality of the first embodiment of the system 10.
  • the positions of the vessel 71 and the second container 80 can be switched. Specifically, the vessel 71 can be positioned where the second container 80 is shown in FIGS. 1-6 while the second container 80 can be positioned where the vessel 71 is shown in FIGS. 1-6. Accordingly, the vessel 71 and the second container 80 can switch positions without affecting the functionality of the first embodiment of the system 10. [0085] In some versions of the first embodiment of the system 10, the positions of the first container 20 and the vessel 71 can be switched. Specifically, the first container 20 can be positioned where the vessel 71 is shown in FIGS. 1-6 while the vessel 71 can be positioned where the first container 20 is shown in FIGS. 1-6. Accordingly, the first container 20 and the vessel 71 can switch positions without affecting the functionality of the first embodiment of the system 10.
  • FIGS. 7-12 show a second embodiment of the system 10 that can be used to supply the composition 21 from the first container 20 to a patient.
  • the first tube 30 and the second tube 40 form a first flow path leading from the first container 20 to the patient.
  • the system 10 can be distal or proximal to an administration set.
  • the first container 20 can be connected to the first tube 30 by an administration set.
  • the second tube 40 can be connected to the patient by an administration set.
  • the second tube 40 and the third tube 50 form a second flow path leading from the patient to the second container 80.
  • the first tube 30, the second tube 40, and the third tube 50 can form a first three-way junction.
  • the first tube 30, the second tube 40 and the third tube 50 are removably attached to or integral with the first three-way junction.
  • the first three-way junction has at least three openings and is not limited to only three openings, although a preferred embodiment of the first three-way junction does indeed have only three openings.
  • the system 10 can comprise a clamp 35 that can selectively have an open position on the first tube 30 in which the first end 31 and the second end 32 of the first tube 30 are open to each other (e.g., the composition 21 can reach the second end 32 of the first tube 30 from the first container 20).
  • the clamp can reversibly move on the first tube 30 between the open position and a blocking position in which the first tube 30 is blocked so that the first end 31 and the second end 32 of the first tube 30 are blocked from each other (e.g., the composition 21 cannot reach the second end 32 of the first tube 30).
  • the clamp 35 can have a first portion 36 having a diameter at least as large as the diameter of the first tube 30 so that the first tube 30 is open when circumscribed by the first portion 36 of the clamp 35.
  • the clamp 35 can have a second portion 37 having a diameter substantially smaller than the diameter of the first tube 30 (e.g., a diameter that is about twice the thickness of the wall of the first tube 30) so that the first tube 30 is blocked when circumscribed by the second portion 37 of the clamp 35.
  • the clamp 35 slides on the first tube 30 in a direction perpendicular to the fluid flow to move between the open position in which the first portion 36 circumscribes the first tube 30 (e.g., the second portion 37 does not circumscribe the first tube 30) and the blocked position in which the second portion 37 circumscribes the first tube 30 (e.g., the first portion 36 does not circumscribe the first tube 30).
  • the clamp 35 in the second embodiment of the system 10 can be any device that can reversibly and selectively open or block the first tube 30, and the present disclosure is not limited to a specific embodiment of the clamp 35.
  • the second end 42 of the second tube 40 can be attached to or integral with an enteral feeding tube and/or an administration set, for example a nasogastric tube, a nasojejeunal tube, a naso-duodenal tube, an orogastric tube, or a percutaneous tube.
  • an enteral feeding tube and/or an administration set for example a nasogastric tube, a nasojejeunal tube, a naso-duodenal tube, an orogastric tube, or a percutaneous tube.
  • the second end 42 of the second tube 40 can be directly attached to the enteral feeding tube or can be attached to the enteral feeding tube by a second intermediate connector 45.
  • the second tube 40 itself can function as the enteral feeding tube.
  • the system 10 can be distal or proximal to the administration set.
  • the first end 51 of the third tube 50 can be fiuidly connected to the second end 32 of the first tube 30 and/or the first end 41 of the second tube 40 at the first three-way junction.
  • the first valve 60 can be positioned at the first three-way junction.
  • the first valve 60 is a single valve that selectively moves between two orientations, each of the orientations forming a different flow path than the other orientation(s).
  • the first valve 60 can be an L-port valve that selectively closes one of three openings of the first valve 60 and fiuidly connects the other two openings of the first valve 60.
  • the first valve 60 is preferably a three-way valve, but instead can be a two-way valve if the system 10 also uses one or more clips, for example one clip or three clips.
  • the third tube 50 and the first valve 60 can selectively direct gastric fluid from the patient into the second container 80.
  • the third tube 50 can lead to a second three-way junction where the first valve 60 is preferably positioned.
  • the second three-way junction has at least three openings and is not limited to only three openings, although a preferred embodiment of the second three-way junction does indeed have only three openings.
  • the second container 80 can be removably attached to or integral with the first valve 60, for example by the third intermediate connector 81.
  • the third intermediate connector 81 is bonded to the third tube 50 and/or the first valve 60 at the second three-way junction.
  • the syringe 70 can be removably attached to or integral with the first valve 60, e.g., the socket 61 of the first valve 60.
  • the first valve 60 preferably moves between at least two orientations, for example a first orientation in which the second end 52 of the third tube 50 is closed and the syringe 70 and the second container 80 are in fluid communication, and a second orientation in which the second container 80 is closed and the second end 52 of the third tube 50 and the syringe 70 and are in fluid communication.
  • the first valve 60 is moved between the first and second orientations by rotation of a stopcock provided by the first valve 60.
  • rotation of the stopcock in one direction can move the first valve 60 from the first orientation to the second orientation
  • rotation of the stopcock in the opposite direction e.g., about 90 degrees
  • the first valve 60 moves between at least three orientations, for example the first and second orientations noted above and additionally a third orientation in which the socket 61 and/or the syringe 70 are closed and the second end 52 of the third tube 50 and the second container 80 are in fluid communication.
  • the first valve 60 is moved between the first, second and third orientations by rotation of a stopcock provided by the first valve 60 (e.g., in about 90 degree increments).
  • the second embodiment of the system 10 can be in a feeding configuration.
  • the clamp 35 can be in the open position, and the first valve 60 can be in the first orientation closing the second end 52 of the third tube 50.
  • the composition 21 can flow from the first container 20 through the first tube 30 and the second tube 40 to the patient, e.g., by gravity or a pump (first flow path, shown by the dashed arrow in this figure).
  • the second embodiment of the system 10 can move from the feeding configuration to a gastric fluid withdrawal configuration.
  • the clamp 35 can be moved to the blocked position.
  • the first valve 60 can be moved into the second orientation fluidly connecting the second end 52 of the third tube 50 to the syringe 70 and closing the second container 80.
  • the plunger 72 of the syringe 70 can be withdrawn from the vessel 71 to pull the gastric fluid through the second tube 40, then through the third tube 50, and then through the first valve 60 into the vessel 71 of the syringe 70 (second flow path, shown by the dashed arrow in this figure).
  • only a portion of the gastric fluid in the patient is removed by one pull of the plunger 72 (i.e., typically one pull of the plunger 72 will not completely empty the gastric fluid from the patient).
  • the volume of the gastric fluid 85 withdrawn into the system 10 can be measured if desired, for example in the syringe 70 and/or the second container 80 using indicia 79 visible thereon.
  • the second embodiment of the system 10 can move from the gastric fluid withdrawal configuration to a drainage container filling configuration, e.g., after the gastric fluid withdrawal configuration is used to withdraw a desired amount of the gastric fluid into the syringe 70 and/or after the system 10 has been in the gastric fluid withdrawal configuration for a desired time period.
  • the first valve 60 can be returned to the first orientation closing the second end 52 of the third tube 50 and fiuidly connecting the syringe 70 and the second container 80.
  • the plunger 72 of the syringe 70 can be pushed into the vessel 71 to direct the gastric fluid 85 from the vessel 71 of the syringe 70 through the first valve 60 into the second container 80 (third flow path, shown by the dashed arrow in this figure).
  • the second embodiment of the system 10 can be returned to the feeding configuration shown in FIG. 7. For example, moving the clamp 35 to the open position, while the first valve 60 is in the first orientation closing the second end 52 of the third tube 50, can arrange the second embodiment of the system 10 into the feeding configuration.
  • additional gastric fluid can be withdrawn by moving the second embodiment of the system 10 from the drainage container filling configuration shown in FIG. 9 back to the gastric fluid withdrawal configuration shown in FIG. 8.
  • moving the first valve 60 from the first orientation, which closes the second end 52 of the third tube 50, to the second orientation, which fiuidly connects the second end 52 of the third tube 50 to the syringe 70 and closes the second container 80, while the clamp 35 is in the blocked position can arrange the system 10 into the gastric fluid withdrawal configuration.
  • the additional gastric fluid can be withdrawn through the second tube 40, the third tube 50 and the first valve 60 into the vessel 71 of the syringe 70 (second flow path, shown by the dashed arrow in this figure).
  • the additional gastric fluid can be directed into the second container 80 using the drainage container filling configuration shown in FIG. 9 (third flow path, shown by the dashed arrow in this figure).
  • the system 10 can move back and forth between the gastric fluid withdrawal configuration and the drainage container filling configuration as many times as desired by the user, until a capacity of the second container 80 is reached, or preferably until the stomach of the patient has been emptied of gastric fluid.
  • the volume of the withdrawn gastric fluid can be measured at any time in this process, for example at least at the end (e.g., the stomach of the patient has been emptied of gastric fluid), for example using the indicia 79 visible on the syringe 70 and/or the second container 80.
  • the second container 80 can be removed from the first valve 60, preferably when the system 10 is positioned in one of the feeding configuration and the gastric fluid withdrawal configuration.
  • the second container 80 can be reversibly removed from the first valve 60 by removing the second container 80 from the third intermediate connector 81 and/or by removing the third intermediate connector 81 from the first valve 60.
  • a subsequent action can be selected from the group consisting of (i) discarding the second container 80 and attaching a new second container 80 to the first valve 60, (ii) dispensing at least a portion of the gastric fluid from the second container 80 and then reconnecting the second container 80 to the first valve 60, and (iii) completely removing the second container 80.
  • the second container 80 can be reconnected to the first valve 60, for example by reconnecting the second container 80 to the third intermediate connector 81 and/or by reconnecting the third intermediate connector 81 to the first valve 60, preferably when the system 10 is positioned in one of the feeding configuration and the gastric fluid withdrawal configuration.
  • the syringe 70 can be removed from the first valve 60.
  • the syringe 70 can be reversibly removed from the first valve 60 by removing the syringe 70 from the socket 61.
  • a subsequent action can be selected from the group consisting of (i) discarding the syringe 70 and attaching a new syringe 70 to the first valve 60, (ii) dispensing at least a portion of the gastric fluid from the syringe 70 and then reconnecting the syringe 70 to the first valve 60, and (iii) completely removing the syringe 70.
  • the syringe 70 can be reconnected to the first valve 60 by reconnecting the syringe 70 to the socket 61.
  • the second embodiment of the system 10 can move from one of the feeding configuration, the gastric fluid withdrawal configuration, and the drainage container filling configuration to a first reinfusion configuration, e.g., after the drainage container filling configuration to a reinfusion configuration is used to direct a desired amount of the gastric fluid into the second container 80 and/or after the system 10 has been in the drainage container filling configuration for a desired time period.
  • the first valve 60 can be moved into the third orientation closing the socket 61 and/or the syringe 70 and fluidly connecting the second end 52 of the third tube 50 and the second container 80.
  • the gastric fluid 85 can be directed from the second container 80 through the first valve 60, then through the third tube 50 and then through the second tube 40 into the gastrointestinal tract of the patient (fourth flow path, shown by the dashed arrow in this figure).
  • the second container 80 can be at least partially flexible so that compression of the second container 80 can force the gastric fluid 85 from the second container 80 through the third tube 50 into the gastrointestinal tract of the patient.
  • FIGS. 11 and 12 A second reinfusion configuration of the second embodiment of the system 10 is shown in FIGS. 11 and 12. This reinfusion configuration is particularly advantageous if the second container 80 is rigid, although this reinfusion configuration can be employed even if the second container 80 is partially flexible.
  • FIG. 11 a first stage of the second reinfusion configuration of the second embodiment of the system 10 is shown.
  • the first valve 60 can be in the first orientation in which the second end 52 of the third tube 50 is blocked and the second container 80 is fluidly connected to the syringe 70.
  • the first valve 60 can fluidly connect the second container 80 and the vessel 71.
  • the plunger 72 of the syringe 70 can be withdrawn from the vessel 71 to pull the gastric fluid 85 from the second container 80 through the first valve 60 into the vessel 71 of the syringe 70 (fifth flow path, shown by the dashed arrow in this figure).
  • FIG. 12 a second stage of the second reinfusion configuration of the second embodiment of the system 10 is shown.
  • the system 10 can be moved from the first stage to the second stage of the second reinfusion configuration by moving the first valve 60 from the first orientation to the second orientation in which the second container 80 is blocked and the second end 52 of the third tube 50 is fiuidly connected to the syringe 70.
  • the third tube 50 can fiuidly connect the second tube 40 and the vessel 71.
  • the plunger 72 of the syringe 70 can be pushed into the vessel 71 to direct the gastric fluid from the vessel 71 through the first valve 60, then through the third tube 50, then through the second tube 40 and then into the gastrointestinal tract of the patient (sixth flow path, shown by the dashed arrow in this figure).
  • the user may perform reinfusion by alternating the first and second stages of the second reinfusion configuration as many times as needed or desired.
  • the first container 20 remains attached to the first tube 30 and/or the first intermediate connector 25 (i.e., the first container 20 is not removed therefrom) throughout movement of the system 10 from the feeding configuration to the gastric fluid withdrawal configuration to the drainage container filling configuration to the reinfusion configuration and back to the feeding configuration.
  • FIGS. 13-18 show a third embodiment of the system 10 that can be used to supply the composition 21 from the first container 20 to a patient.
  • the first tube 30, the second tube 40 and the third tube 50 can be connected together to form the first three-way junction as discussed above with respect to the second embodiment.
  • the first valve 60 is preferably positioned at the first three-way junction (i.e., the intersection of the first tube 30, the second tube 40 and the third tube 50) instead of the second three-way junction.
  • the third embodiment of the system 10 preferably comprises a syringe tube 55 that fiuidly connects the syringe 70 to the second end 52 of the third tube 50 at the second three-way junction.
  • the syringe tube 55 can be integral with or removably connected to the second three- way junction.
  • the system 10 can comprise the fourth tube 57, and the fourth tube 57 can extend from the second three-way junction to the third intermediate connector 81 and/or the second container 80.
  • a first end 58 of the fourth tube 57 can be fiuidly connected to the syringe tube 55 and the third tube 50 at the second three-way junction.
  • a second end 59 of the fourth tube 57 can be fiuidly connected to the third intermediate connector 81 and/or the second container 80.
  • the clamp 35 is preferably positioned on the fourth tube 57.
  • the clamp 35 in the third embodiment of the system 10 can reversibly move on the fourth tube 57 between a blocked position in which the fourth tube 57 is blocked so that gastric fluid from the first valve 60 is directed to the syringe 70 and an open position in which the syringe 70 can direct the gastric fluid from the syringe 70 through the fourth tube 57 to the second container 80 when the first valve 60 closes the first end 51 of the third tube 50.
  • the first portion 36 of the clamp 35 can have a diameter at least as large as the diameter of the fourth tube 57 so that the fourth tube 57 is open when circumscribed by the first portion 36 of the clamp 35.
  • the second portion 37 of the clamp 35 can have a diameter substantially smaller than the diameter of the fourth tube 57 (e.g., a diameter that is about twice the thickness of the wall of the fourth tube 57) so that the fourth tube 57 is blocked when circumscribed by the second portion 37 of the clamp 35.
  • the clamp 35 slides on the fourth tube 57 in a direction perpendicular to the fluid flow to move between the open position in which the first portion 36 circumscribes the fourth tube 57 (e.g., the second portion 37 does not circumscribe the fourth tube 57) and the blocked position in which the second portion 37 circumscribes the fourth tube 57 (e.g., the first portion 36 does not circumscribe the fourth tube 57).
  • the clamp 35 in the third embodiment can be any device that can reversibly and selectively open and block the fourth tube 57, and the present disclosure is not limited to a specific embodiment of the clamp 35.
  • the first valve 60 is moved between a first orientation in which the first tube 30 is fiuidly connected to the second tube 40, and the first end 51 of the third tube 50 is blocked, and a second orientation in which the second tube 40 is fiuidly connected to the third tube 50, and the second end 32 of the first tube 30 is blocked.
  • the first valve 60 can be moved between the first and second positions by rotation of a stopcock provided by the first valve 60.
  • rotation of the stopcock in one direction can move the first valve 60 from the first position to the second position
  • rotation of the stopcock in the opposite direction e.g., about 90 degrees
  • the third embodiment of the system 10 can be in a feeding configuration.
  • the first valve 60 can be in a first orientation closing the first end 51 of the third tube 50 and fiuidly connecting the second end 32 of the first tube 30 to the first end 41 of the second tube 40.
  • the composition 21 flows from the first container 20 through the first tube 30 and the second tube 40 to the patient, e.g., by gravity or a pump (first flow path, shown by the dashed arrow).
  • the third embodiment of the system 10 can move from the feeding configuration to a gastric fluid withdrawal configuration.
  • the clamp 35 can be moved to the blocked position.
  • the first valve 60 can be moved into the second position which closes the second end 32 of the first tube 30 while fiuidly connecting the first end 41 of the second tube 40 to the first end 51 of the third tube 50.
  • the plunger 72 of the syringe 70 can be withdrawn from the vessel 71 to pull the gastric fluid through the second tube 40, then through the first valve 60, then through the third tube 50, and then through the syringe tube 55 into the vessel 71 of the syringe 70 (second flow path, shown by the dashed arrow).
  • only a portion of the gastric fluid in the patient is removed by one pull of the plunger 72 (i.e., typically one pull of the plunger 72 will not completely empty the gastric fluid from the patient).
  • the volume of the gastric fluid 85 withdrawn into the system 10 can be measured if desired, for example in the syringe 70 and/or the second container 80 using indicia 79 visible thereon.
  • the third embodiment of the system 10 can move from the gastric fluid withdrawal configuration to a drainage container filling configuration, e.g., after the gastric fluid withdrawal configuration is used to withdraw a desired amount of the gastric fluid into the syringe 70.
  • the first valve 60 can be returned to the first orientation closing the first end 51 of the third tube 50, and the clamp 35 can be moved to the open position.
  • the open position of the clamp 35 can fiuidly connect the syringe 70 and the second container 80 via the fourth tube 57 and optionally the third intermediate connector 81.
  • the drainage container filling configuration can also function as the feeding configuration shown in FIG. 10.
  • the composition 21 can flow from the first container 20 through the first tube 30 and the second tube 40 to the patient (first flow path) when the system 10 is still in the drainage container filling configuration (third flow path).
  • the third embodiment of the system 10 can move back and forth between the gastric fluid withdrawal configuration and the drainage container filling configuration as many times as desired by the user, until a capacity of the second container 80 is reached, or preferably until the stomach of the patient has been emptied of gastric fluid.
  • the volume of the withdrawn gastric fluid can be measured at any time in this process, for example least at the end (e.g., the stomach of the patient has been emptied of gastric fluid), for example using the indicia 79 visible on the syringe 70 and/or the second container 80.
  • the second container 80 can be removed from the fourth tube 57, preferably when the system 10 is positioned in one of the feeding configuration and the gastric fluid withdrawal configuration.
  • the second container 80 can be reversibly removed from the fourth tube 57 by removing the second container 80 from the third intermediate connector 81 and/or removing the third intermediate connector 81 from the fourth tube 57.
  • a subsequent action can be selected from the group consisting of (i) discarding the second container 80 and attaching a new second container 80 to the fourth tube 57, (ii) dispensing at least a portion of the gastric fluid from the second container 80 and then reconnecting the second container 80 to the fourth tube 57, and (iii) completely removing the second container 80.
  • the second container 80 can be reconnected to the fourth tube 57, for example by reconnecting the second container 80 to the third intermediate connector 81 and/or by reconnecting the third intermediate connector 81 to the fourth tube 57, preferably when the system 10 is positioned in one of the feeding configuration and the gastric fluid withdrawal configuration.
  • the syringe 70 can be removed from the second three- way junction.
  • the syringe 70 can be reversibly removed from the second three-way junction by removing the syringe 70 from the syringe tube 55.
  • a subsequent action can be selected from the group consisting of (i) discarding the syringe 70 and attaching a new syringe 70 to the second three-way junction, (ii) dispensing at least a portion of the gastric fluid from the syringe 70 and then reconnecting the syringe 70 to the second three- way junction, and (iii) completely removing the syringe 70.
  • the syringe 70 can be reconnected to the second three-way junction, for example by reconnecting the syringe 70 to the syringe tube 55.
  • the third embodiment of the system 10 can move from one of the feeding configuration, the gastric fluid withdrawal configuration, and the drainage container filling configuration to a first reinfusion configuration, e.g., after the drainage container filling configuration is used to direct a desired amount of the gastric fluid into the second container 80 and/or after the system 10 has been in the drainage container filling configuration for a desired time period.
  • the clamp 35 can be in the open position, and the first valve 60 can be moved into the second orientation blocking the second end 32 of the first tube 30 and fiuidly connecting the first end 51 of the third tube 50 and the first end 41 of the second tube 40.
  • the fourth tube 57, the third tube 50 and the first valve 60 can fiuidly connect the second container 80 to the second tube 40. Then the gastric fluid 85 can be directed from the second container 80 through the fourth tube 57, then though the third tube 50, then through the first valve 60, and then through the second tube 40 into the gastrointestinal tract of the patient (fourth flow path, shown by the dashed arrow in this figure).
  • the second container 80 can be at least partially flexible so that compression of the second container 80 can force the gastric fluid 85 from the second container 80 through the fourth tube 57, the third tube 50, the first valve 60 and the second tube 40 into the gastrointestinal tract of the patient.
  • FIGS. 17 and 18 A second reinfusion configuration of the third embodiment of the system 10 is shown in FIGS. 17 and 18. This reinfusion configuration is particularly advantageous if the second container 80 is rigid, although this reinfusion configuration can be employed even if the second container 80 is partially flexible.
  • FIG. 17 a first stage of the second reinfusion configuration of the third embodiment of the system 10 is shown.
  • the first valve 60 can be in the first orientation in which the first end 52 of the third tube 50 is blocked, and the clamp 35 can be in the open position in which the second container 80 is fiuidly connected to the vessel 71 by the fourth tube 57.
  • the plunger 72 of the syringe 70 can be withdrawn from the vessel 71 to pull the gastric fluid from the second container 80 through the fourth tube 57 into the vessel 71 of the syringe 70 (fifth flow path, shown by the dashed arrow in this figure).
  • FIG. 18 a second stage of the second reinfusion configuration of the third embodiment of the system 10 is shown.
  • the system 10 can be moved from the first stage to the second stage of the second reinfusion configuration by moving the first valve 60 from the first orientation to the second orientation in which the second end 32 of the first tube 30 is blocked and the first end 51 of the third tube 50 is fiuidly connected to the first end 41 of the second tube 40, while the clamp 35 is in the blocked position in which the second container 80 is closed.
  • the third tube 50 and the first valve 60 can fiuidly connect the second tube 40 and the vessel 71.
  • the plunger 72 of the syringe 70 can be pushed into the vessel 71 to direct the gastric fluid from the vessel 71 through the third tube 50, then through the first valve 60, then through the second tube 40 and then into the gastrointestinal tract of the patient (sixth flow path, shown by the dashed arrow in this figure).
  • the user may perform reinfusion by alternating the first and second stages of the second reinfusion configuration as many times as needed or desired.
  • the first container 20 remains attached to the first tube 30 and/or the first intermediate connector 25 (i.e., the first container 20 is not removed therefrom) throughout movement from the feeding configuration to the gastric fluid withdrawal configuration to the drainage container filling configuration to the reinfusion configuration and back to the feeding configuration.
  • FIGS. 19-21 show a fourth embodiment of the system 10 that can be used to supply the composition 21 from the first container 20 to a patient.
  • the fourth embodiment can be configured similarly to the third embodiment, except a one-way valve 38 can replace the clamp 35.
  • the one-way valve 38 can be any valve that only allows one direction of fluid flow (e.g., a check valve having a desired cracking pressure), and the present disclosure is not limited to a specific embodiment of the one-way valve 38.
  • the one-way valve 38 can advantageously remove the need to move the clamp 35 between the blocked and open positions, such that fluid flow can be controlled solely by the first valve 60 and/or the syringe 70.
  • a preferred feature of the fourth embodiment of the system 10 is that the drainage container filling configuration can also function as the feeding configuration shown in FIG. 19.
  • the composition 21 can flow from the first container 20 through the first tube 30, then through the first valve 60, and then through the second tube 40 to the patient (first flow path) when the system 10 is in the drainage container filling configuration (third flow path).
  • FIG. 22A generally illustrates a configuration in which the system 10 can be used; the first container 20 can be connected to an administration set 100 which in turn is connected to the system 10 which in turn is connected to a feeding tube 150 that leads to the patient 200.
  • FIG. 22B generally illustrates another configuration in which the system 10 can be used; the first container 20 can be connected to the system 10 which in turn is connected to an administration set 100 which in turn is connected to a feeding tube 150 that leads to the patient 200.
  • Any embodiment of the system 10 e.g., any of the first, second, third and fourth embodiments, can be used in the configuration shown in FIG. 22 A and the configuration shown in FIG. 22B.
  • the system 10 and the administration set 100 are used with one or more extension lines 200 that can be one or more tubes that extend the length of the administration set 100.
  • FIGS. 22A and 22B show the system 10 proximal to the patient from the one or more extension lines 200, but these figures are merely a non-limiting example, and the system 10 can be proximal from one or more of the extension lines 200 relative to the patient 200 and/or distal from one or more of the extension lines 200 relative to the patient 200.
  • the administration set 100 comprises a medication port which can be a Y-port.
  • the system 10 can be connected to the medication port; additionally or alternatively, one or more of the extension lines 200 can be connected to the medication port.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

L'invention concerne une composition contenant un nutriment et/ou un médicament qui peut être administrée à un patient par l'intermédiaire d'un tube d'alimentation entérale, et le même tube d'alimentation entérale peut être utilisé pour une aspiration active telle qu'un drainage de liquide gastrique. Dans un aspect, le liquide gastrique peut être aspiré avec une seringue, puis une valve peut être commutée pour vider la seringue dans un récipient relié de manière fluidique à la seringue, et après l'aspiration et la collecte du liquide gastrique, le récipient peut être vidé (par exemple, jeté) et/ou le liquide gastrique peut être renvoyé à l'estomac.
EP18711074.7A 2017-03-16 2018-03-12 Système d'alimentation entérale fermé pour le drainage de liquide gastrique Pending EP3595613A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762472304P 2017-03-16 2017-03-16
PCT/EP2018/056001 WO2018166936A1 (fr) 2017-03-16 2018-03-12 Système d'alimentation entérale fermé pour le drainage de liquide gastrique

Publications (1)

Publication Number Publication Date
EP3595613A1 true EP3595613A1 (fr) 2020-01-22

Family

ID=61628346

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18711074.7A Pending EP3595613A1 (fr) 2017-03-16 2018-03-12 Système d'alimentation entérale fermé pour le drainage de liquide gastrique

Country Status (2)

Country Link
EP (1) EP3595613A1 (fr)
WO (1) WO2018166936A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2230218A (en) * 1938-06-02 1941-02-04 Walter F Asche Gastro-intestinal treatment system
WO2012017547A1 (fr) * 2010-08-06 2012-02-09 イーエヌ大塚製薬株式会社 Clapet anti-retour, unité de robinet d'arrêt à trois voies et outil de transfert de substance fluide
US20120283627A1 (en) * 2011-05-06 2012-11-08 Gerald Moss Method for combined gastrointestional feeding and aspiration

Also Published As

Publication number Publication date
WO2018166936A1 (fr) 2018-09-20

Similar Documents

Publication Publication Date Title
US4915688A (en) Apparatus for administering solution to a patient
EP1790376B1 (fr) Adapteur à lumière unique pour valve automatique
EP2944342B1 (fr) Alimentation enterale et systeme de collecte de reflux
US20040039346A1 (en) Apparatus and method for administration of IV liquid medication and IV flush solutions
JP4332432B2 (ja) 留置投与に用いる投薬容器
US20120283627A1 (en) Method for combined gastrointestional feeding and aspiration
EP3595613A1 (fr) Système d'alimentation entérale fermé pour le drainage de liquide gastrique
CN211271054U (zh) 可拆卸穿刺器注射管路系统
CN112351805B (zh) 带通气套环的肠内注射器
CN215426206U (zh) 一次性使用双通道肠内营养输注器
CN101327347B (zh) 一次性结肠灌洗给药透析器
CN221061272U (zh) 一种伞式防逆返空肠营养导管
CN113559340B (zh) 一种能够检测营养液成分的循环系统
CN219022361U (zh) 一种一次性肠胃营养输注管路
CN109010991A (zh) 输液器与取样方法和冲管方法
CN216169190U (zh) 一种可直接给药、连接泵管的输液器
CN217311209U (zh) 一种可控式多功能管道冲洗器
CN212756472U (zh) 分隔过滤式肠内营养输注器
CN212973572U (zh) 分离式肠内营养输注系统
CN211157413U (zh) 一种一次性使用泵奶延长管
CN213698303U (zh) 一种三通式输液器
CN211024195U (zh) 用于一次性肠给养器的辅助过滤装置
CN212016197U (zh) 一种改良的五腔胃管
CN2912649Y (zh) 一次性双通冲洗灌药器
CN209019474U (zh) 一种胃肠辅助器

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191015

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20221010